User profiles for A. W. Berger
Arthur W BergerAkamai Technologies and MIT CSAIL Verified email at mit.edu Cited by 6601 |
Fast portscan detection using sequential hypothesis testing
Attackers routinely perform random portscans of IP addresses to find vulnerable servers to
compromise. Network intrusion detection systems (NIDS) attempt to detect such behavior and …
compromise. Network intrusion detection systems (NIDS) attempt to detect such behavior and …
Fast detection of scanning worm infections
SE Schechter, J Jung, AW Berger - … September 15-17, 2004. Proceedings 7, 2004 - Springer
Worm detection and response systems must act quickly to identify and quarantine scanning
worms, as when left unchecked such worms have been able to infect the majority of …
worms, as when left unchecked such worms have been able to infect the majority of …
NIRA: a new inter-domain routing architecture
… AW Berger is with MIT CSAIL and Akamai Technologies, Cambridge, MA 02139 USA. …
Berger received the Ph.D. degree in applied mathematics from Harvard University, Cambridge, MA…
Berger received the Ph.D. degree in applied mathematics from Harvard University, Cambridge, MA…
Plenty of room for carbon on the ground: Potential applications of biochar for stormwater treatment
Low impact development (LID) systems are increasingly used to manage stormwater, but they
have limited capacity to treat stormwater—a resource to supplement existing water supply …
have limited capacity to treat stormwater—a resource to supplement existing water supply …
Modeling TTL-based Internet caches
J Jung, AW Berger… - IEEE INFOCOM 2003 …, 2003 - ieeexplore.ieee.org
This paper presents a way of modeling the hit rates of caches that use a time-to-live (TTL)-based
consistency policy. TTL-based consistency, as exemplified by DNS and Web caches, is …
consistency policy. TTL-based consistency, as exemplified by DNS and Web caches, is …
Real time pricing to assist in load frequency control
AW Berger, FC Schweppe - IEEE Transactions on Power …, 1989 - ieeexplore.ieee.org
The use of real-time prices (ie pricing in the presence of system dynamics) to assist in the
control of frequency and tie-line deviations in electric power systems is discussed. Under …
control of frequency and tie-line deviations in electric power systems is discussed. Under …
[HTML][HTML] Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—A randomized phase II trial of the AIO pancreatic …
…, A Hinke, L Blome, A Tannapfel, A Kleger, AW Berger… - Annals of …, 2023 - Elsevier
Background Data on perioperative chemotherapy in resectable pancreatic ductal adenocarcinoma
(rPDAC) are limited. NEONAX examined perioperative or adjuvant chemotherapy …
(rPDAC) are limited. NEONAX examined perioperative or adjuvant chemotherapy …
[HTML][HTML] Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information
…, A Kleger, L Bullinger, T Seufferlein, AW Berger - Scientific reports, 2019 - nature.com
Diagnosis of Cholangiocarcinoma (CCA) is difficult, thus a noninvasive approach towards (i)
assessing and (ii) monitoring the tumor-specific mutational profile is desirable to improve …
assessing and (ii) monitoring the tumor-specific mutational profile is desirable to improve …
Detection of hot-spot mutations in circulating cell-free DNA from patients with intraductal papillary mucinous neoplasms of the pancreas
AW Berger, D Schwerdel, IG Costa, T Hackert… - Gastroenterology, 2016 - Elsevier
Intraductal papillary mucinous neoplasms (IPMNs) are the most frequent cystic pancreatic
tumors. Little is known about their molecular alterations, but mutations in GNAS have been …
tumors. Little is known about their molecular alterations, but mutations in GNAS have been …
[HTML][HTML] Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer-the NEONAX trial (AIO-PAK-0313), a …
TJ Ettrich, AW Berger, L Perkhofer, S Daum, A König… - BMC cancer, 2018 - Springer
Background Even clearly resectable pancreatic cancer still has an unfavorable prognosis.
Neoadjuvant or perioperative therapies might improve the prognosis of these patients. Thus, …
Neoadjuvant or perioperative therapies might improve the prognosis of these patients. Thus, …